An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results.
Click here for original story, Experimental COVID-19 vaccine safe, generates immune response
Source: ScienceDaily